Výstupy z registru ČNHP za rok 2017 – hemofilie |

The status of care for persons with haemophilia registered in the CNHP registry: Annual Report 2017 |

Sample size, valid records |

Part A: Persons with haemophilia |

Centres participating in CNHP |

Basic demographics |

Persons with haemophilia and inhibitors in 2017 |

ABR and treatment regimen in patients with inhibitor |

ABR according to treatment regimen in PWH with inhibitor |

Part A1: Demographic characteristics – haemophilia A |

Severity of haemophilia A |

Age at diagnosis according to severity of haemophilia A |

Actual age according to severity of haemophilia A |

Hepatitis (ever) experienced: paediatric patients, haemophilia A |

Hepatitis (ever) experienced: adult patients, haemophilia A |

HIV: all patients, haemophilia A |

Part A2: Treatment outcomes and bleeding frequency – haemophilia A |

Data from year 2017 – sample size: all patients, haemophilia A |

Frequency of bleeding requiring treatment in 2017: haemophilia A |

Location of bleeds in 2017: paediatric patients, haemophilia A |

Location of bleeds in 2017: adult patients, haemophilia A |

Preventive administration in 2017: paediatric patients, haemophilia A |

Preventive administration in 2017: adult patients, haemophilia A |

Part A3: ABR according to treatment regimen – haemophilia A without inhibitor |

Annual bleeding rate according to treatment regimen: paediatric patients, haemophilia A |

Joint and other bleeds according to treatment regimen: paediatric patients, haemophilia A |

Annual bleeding rate according to treatment regimen: adult patients, haemophilia A |

Joint and other bleeds according to treatment regimen: adult patients, haemophilia A |

ABR according to treatment regimen and age: adult patients, haemophilia A |

Joint and other bleeds according to treatment regimen and age: adult patients, haemophilia A |

Part A4: ABR according to centres – haemophilia A (PWHA) |

Annual bleeding rate on permanent prophylaxis: PWHA on prophylaxis, paediatric centres |

Annual bleeding rate on permanent prophylaxis: PWHA on prophylaxis, adult centres |

Annual bleeding rate regardless prophylaxis: PWHA, paediatric centres |

Annual bleeding rate regardless prophylaxis: PWHA, adult centres |

Prophylactic regimens and treatment outcomes: PWHA, paediatric centres |

Prophylactic regimens and treatment outcomes: PWHA, adult centres |

Type of treatment (subgroup of treated patients): paediatric patients, haemophilia A |

Type of treatment (subgroup of treated patients): adult patients, haemophilia A |

Part B1: Demographic characteristics – haemophilia B |

Severity of haemophilia B |

Age at diagnosis according to severity of haemophilia B |

Actual age according to severity of haemophilia B |

Hepatitis (ever) experienced: paediatric patients, haemophilia B |

Hepatitis (ever) experienced: adult patients, haemophilia B |

HIV: all patients, haemophilia B |

Part B2: Treatment outcomes and bleeding frequency – haemophilia B |

Data from year 2017 – sample size: all patients, haemophilia B |

Frequency of bleeding requiring treatment in 2017: haemophilia B |

Location of bleeds in 2017: paediatric patients, haemophilia B |

Location of bleeds in 2017: adult patients, haemophilia B |

Preventive administration in 2017: paediatric patients, haemophilia B |

Preventive administration in 2017: adult patients, haemophilia B |

Part B3: ABR according to treatment regimen – haemophilia B without inhibitor |

Annual bleeding rate according to treatment regimen: paediatric patients, haemophilia B |

Joint and other bleeds according to treatment regimen: paediatric patients, haemophilia B |

Annual bleeding rate according to treatment regimen: adult patients, haemophilia B |

Joint and other bleeds according to treatment regimen: adult patients, haemophilia B |

Part B4: ABR according to centres – haemophilia B (PWHB) |

Annual bleeding rate on permanent prophylaxis: PWHB on prophylaxis, paediatric centres |

Annual bleeding rate on permanent prophylaxis: PWHB on prophylaxis, adult centres |

Annual bleeding rate regardless prophylaxis: PWHB, paediatric centres |

Annual bleeding rate regardless prophylaxis: PWHB, adult centres |

Prophylactic regimens and treatment outcomes: PWHB, paediatric centres |

Prophylactic regimens and treatment outcomes: PWHB, adult centres |

Type of treatment (subgroup of treated patients): paediatric patients, haemophilia B |

Type of treatment (subgroup of treated patients): adult patients, haemophilia B |

Part C1: Treatment data and factor consumption – haemophilia A and B |

Treatment: all patients |

Treatment: paediatric patients |

Treatment: adult patients |

Comparison of treatment in years 2017 and 2016: all patients |

Comparison of treatment in years 2017 and 2016: paediatric patients |

Comparison of treatment in years 2017 and 2016: adult patients |

Consumption of drugs: all patients |

Consumption of drugs: paediatric patients |

Consumption of drugs: adult patients |
|
|